These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 4668399)
41. [Thrombelastography indices on the activity status and remission of polycythemia rubra vera]. Siro B; Nagy G; Misz M; Szegedi J Rev Clin Esp; 1972 Feb; 124(4):395-8. PubMed ID: 5022304 [No Abstract] [Full Text] [Related]
42. [Treatment of chronic myeloid leukemia with Dibromomannitol]. Saillen R; Clément F Schweiz Rundsch Med Prax; 1970 Sep; 59(38):1325-33. PubMed ID: 5283076 [No Abstract] [Full Text] [Related]
43. [Hydroxyurea in the treatment of erythremia]. Demidova AV Ter Arkh; 1993; 65(9):82-4. PubMed ID: 8303607 [No Abstract] [Full Text] [Related]
46. [Tyrosine kinase inhibitors in the treatment of polycythemia vera and related conditions. Danish Society of Hematology]. Larsen TS; Hasselbalch HC; Ugeskr Laeger; 2008 Mar; 170(12):1031. PubMed ID: 18397649 [No Abstract] [Full Text] [Related]
47. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera. Fruchtman SM; Mack K; Kaplan ME; Peterson P; Berk PD; Wasserman LR Semin Hematol; 1997 Jan; 34(1):17-23. PubMed ID: 9025158 [No Abstract] [Full Text] [Related]
48. [The treatment of polycythemia vera with busulfan]. Kratochvil J; Mrkos D Vnitr Lek; 1966 Jul; 12(7):673-81. PubMed ID: 5967585 [No Abstract] [Full Text] [Related]
49. Management of polycythaemia vera. Med J Aust; 1965 Oct; 2(16):673-4. PubMed ID: 5836293 [No Abstract] [Full Text] [Related]
50. Clinical application of myelobromol in chronic myeloses. Cerný V; Ujházy V; Sándor L; Winkler A; Uhrínová M; Petrek C; Halko J Neoplasma; 1966; 13(2):177-80. PubMed ID: 5222995 [No Abstract] [Full Text] [Related]
51. Polycythemia vera: diagnosis and treatment 2002. Berlin NI Expert Rev Anticancer Ther; 2002 Jun; 2(3):330-6. PubMed ID: 12113056 [TBL] [Abstract][Full Text] [Related]
52. The thromboelastographic index in the periods of recurrence and remission of polycythaemia vera. Nagy G; Misz M; Siró B; Szegedi J Acta Med Acad Sci Hung; 1971; 28(3):205-9. PubMed ID: 5153638 [No Abstract] [Full Text] [Related]
53. Stilbestrol in the treatment of polycythemia vera. Wirth L Med Times; 1968 Sep; 96(9):913-5. PubMed ID: 5672958 [No Abstract] [Full Text] [Related]
54. Polycythemia vera in a 12-year-old girl: a case report. Turker M; Ozer EA; Oniz H; Atabay B; Yaprak I Pediatr Hematol Oncol; 2002 Jun; 19(4):263-6. PubMed ID: 12051593 [TBL] [Abstract][Full Text] [Related]
55. [Experience in preventive therapy of patients with chronic coronary insufficiency under polyclinic conditions]. Paranskaia ZhA Klin Med (Mosk); 1970 Apr; 48(4):109-12. PubMed ID: 5425704 [No Abstract] [Full Text] [Related]
56. [Diagnosis of coronary insufficiency under polyclinic conditions]. Kuz'ko NV; Vasilenko LA Vrach Delo; 1973 May; 5():30-3. PubMed ID: 4757728 [No Abstract] [Full Text] [Related]
57. [Myelobromol treatment of patients with chronic myeloleukosis]. Cherntsova TA; Klimova NF; Susoeva VM Klin Med (Mosk); 1967 Jul; 45(7):96-104. PubMed ID: 5250315 [No Abstract] [Full Text] [Related]
58. [A case of polycythemia vera treated with myleran]. Migdal A Wiad Lek; 1966 May; 19(9):737-9. PubMed ID: 5963614 [No Abstract] [Full Text] [Related]
59. Clinical pharmacology of dibromohexitols. Eckhardt S Haematologica; 1972 Apr; 57(11):722-31. PubMed ID: 4200307 [No Abstract] [Full Text] [Related]